The epidemiology of alcohol use disorders cross-nationally: Findings from the World Mental Health Surveys.
Abuse
Alcohol
Comorbidity
Dependence
Prevalence
Remission
Journal
Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
08
05
2019
revised:
24
08
2019
accepted:
09
09
2019
pubmed:
23
12
2019
medline:
23
1
2021
entrez:
23
12
2019
Statut:
ppublish
Résumé
Prevalences of Alcohol Use Disorders (AUDs) and Mental Health Disorders (MHDs) in many individual countries have been reported but there are few cross-national studies. The WHO World Mental Health (WMH) Survey Initiative standardizes methodological factors facilitating comparison of the prevalences and associated factors of AUDs in a large number of countries to identify differences and commonalities. Lifetime and 12-month prevalence estimates of DSM-IV AUDs, MHDs, and associations were assessed in the 29 WMH surveys using the WHO CIDI 3.0. Prevalence estimates of alcohol use and AUD across countries and WHO regions varied widely. Mean lifetime prevalence of alcohol use in all countries combined was 80%, ranging from 3.8% to 97.1%. Combined average population lifetime and 12-month prevalence of AUDs were 8.6% and 2.2% respectively and 10.7% and 4.4% among non-abstainers. Of individuals with a lifetime AUD, 43.9% had at least one lifetime MHD and 17.9% of respondents with a lifetime MHD had a lifetime AUD. For most comorbidity combinations, the MHD preceded the onset of the AUD. AUD prevalence was much higher for men than women. 15% of all lifetime AUD cases developed before age 18. Higher household income and being older at time of interview, married, and more educated, were associated with a lower risk for lifetime AUD and AUD persistence. Prevalence of alcohol use and AUD is high overall, with large variation worldwide. The WMH surveys corroborate the wide geographic consistency of a number of well-documented clinical and epidemiological findings and patterns.
Sections du résumé
BACKGROUND
Prevalences of Alcohol Use Disorders (AUDs) and Mental Health Disorders (MHDs) in many individual countries have been reported but there are few cross-national studies. The WHO World Mental Health (WMH) Survey Initiative standardizes methodological factors facilitating comparison of the prevalences and associated factors of AUDs in a large number of countries to identify differences and commonalities.
METHODS
Lifetime and 12-month prevalence estimates of DSM-IV AUDs, MHDs, and associations were assessed in the 29 WMH surveys using the WHO CIDI 3.0.
RESULTS
Prevalence estimates of alcohol use and AUD across countries and WHO regions varied widely. Mean lifetime prevalence of alcohol use in all countries combined was 80%, ranging from 3.8% to 97.1%. Combined average population lifetime and 12-month prevalence of AUDs were 8.6% and 2.2% respectively and 10.7% and 4.4% among non-abstainers. Of individuals with a lifetime AUD, 43.9% had at least one lifetime MHD and 17.9% of respondents with a lifetime MHD had a lifetime AUD. For most comorbidity combinations, the MHD preceded the onset of the AUD. AUD prevalence was much higher for men than women. 15% of all lifetime AUD cases developed before age 18. Higher household income and being older at time of interview, married, and more educated, were associated with a lower risk for lifetime AUD and AUD persistence.
CONCLUSIONS
Prevalence of alcohol use and AUD is high overall, with large variation worldwide. The WMH surveys corroborate the wide geographic consistency of a number of well-documented clinical and epidemiological findings and patterns.
Identifiants
pubmed: 31865172
pii: S0306-4603(19)30489-7
doi: 10.1016/j.addbeh.2019.106128
pmc: PMC7416527
mid: NIHMS1615482
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
106128Subventions
Organisme : NIDA NIH HHS
ID : R01 DA016558
Pays : United States
Organisme : FIC NIH HHS
ID : R03 TW006481
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH069864
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH061905
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH060220
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH070884
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA044170
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH059575
Pays : United States
Organisme : NIMH NIH HHS
ID : R13 MH066849
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2019. Published by Elsevier Ltd.
Références
Alcohol Alcohol. 2015 May;50(3):310-8
pubmed: 25716113
Alcohol Clin Exp Res. 2015 Sep;39(9):1712-26
pubmed: 26331879
Addiction. 2014 Jun;109(6):922-9
pubmed: 24717214
Clin Psychol Sci. 2014 Mar;2(2):119-137
pubmed: 25360393
Addiction. 2018 Oct;113(10):1905-1926
pubmed: 29749059
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
Int J Methods Psychiatr Res. 2016 Jun;25(2):79-85
pubmed: 27133364
Soc Psychiatry Psychiatr Epidemiol. 2005 Sep;40(9):681-90
pubmed: 16160752
PLoS One. 2013 Jun 24;8(6):e65514
pubmed: 23826081
Alcohol Alcohol. 2005 Jul-Aug;40(4):327-35
pubmed: 15824065
Eur Neuropsychopharmacol. 2005 Aug;15(4):357-76
pubmed: 15961293
Arch Gen Psychiatry. 1981 Apr;38(4):381-9
pubmed: 6260053
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070
Eur J Public Health. 2015 Apr;25 Suppl 2:69-72
pubmed: 25805792
Eur Neuropsychopharmacol. 2005 Aug;15(4):377-88
pubmed: 15925491
Arch Gen Psychiatry. 2004 Aug;61(8):807-16
pubmed: 15289279
Int J Methods Psychiatr Res. 2006;15(4):167-80
pubmed: 17266013
Arch Gen Psychiatry. 2011 Jan;68(1):90-100
pubmed: 21199968
J Abnorm Psychol. 2017 May;126(4):454-477
pubmed: 28333488
Alcohol Clin Exp Res. 2018 Oct;42(10):1939-1950
pubmed: 30080258
Dev Psychopathol. 2000 Autumn;12(4):795-814
pubmed: 11202044
Soc Psychiatry Psychiatr Epidemiol. 2017 Jul;52(7):887-899
pubmed: 28220214
Int Rev Psychiatry. 2008 Oct;20(5):425-33
pubmed: 19012127
Lancet. 2009 Jun 27;373(9682):2223-33
pubmed: 19560604
Lancet. 2018 Apr 14;391(10129):1513-1523
pubmed: 29676281
Arch Pediatr Adolesc Med. 2011 Feb;165(2):152-8
pubmed: 20921343
Dev Psychol. 2015 Jul;51(7):962-74
pubmed: 26010381
Addiction. 2010 Jun;105(6):1117-28
pubmed: 20331554
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Addict Behav. 1998 Nov-Dec;23(6):893-907
pubmed: 9801724
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
Am J Addict. 2014 Mar-Apr;23(2):145-55
pubmed: 25187050
Drug Alcohol Rev. 2005 Nov;24(6):515-23
pubmed: 16361208
Drug Alcohol Depend. 2015 Sep 1;154:1-13
pubmed: 26072219
Int J Methods Psychiatr Res. 2004;13(2):122-39
pubmed: 15297907
Soc Sci Med. 2016 Aug;162:158-67
pubmed: 27367897
Addiction. 2014 Nov;109(11):1824-32
pubmed: 24845951
J Stud Alcohol Suppl. 1999 Mar;13:139-46
pubmed: 10225498
Drug Alcohol Rev. 2006 Nov;25(6):515-36
pubmed: 17132571
Soc Sci Med. 2005 Oct;61(8):1658-67
pubmed: 15869834
Perspect Psychol Sci. 2019 May;14(3):419-436
pubmed: 30844330
Public Health. 2012 Jan;126(1):3-11
pubmed: 22137093
Eur Addict Res. 2003 Oct;9(4):147-56
pubmed: 12970583
Arch Gen Psychiatry. 2007 Jul;64(7):830-42
pubmed: 17606817
Alcohol Alcohol. 2003 Nov-Dec;38(6):537-42
pubmed: 14633640